Genesis Growth Tech Acquisition Corp. Watch

from 425 39 pages Contribution and Business Combination Agreement Dated November 20, 2023 by and Between Genesis Growth Tech Acquisition Corp. and Genesis Growth Tech LLC

from 8-K 39 pages Contribution and Business Combination Agreement Dated November 20, 2023 by and Between Genesis Growth Tech Acquisition Corp. and Genesis Growth Tech LLC

from 425 80 pages Agreement and Plan of Merger by and Among Genesis Growth Tech Acquisition Corp. as the Purchaser, Ggac Merger Sub, Inc., as Merger Sub, Eyal Perez in the Capacity as the Purchaser Representative, William Kerby in the Capacity as the Seller Representative, and Nexttrip Holdings, Inc., as the Company, Dated as of May 22, 2023

from 8-K 80 pages Agreement and Plan of Merger by and Among Genesis Growth Tech Acquisition Corp. as the Purchaser, Ggac Merger Sub, Inc., as Merger Sub, Eyal Perez in the Capacity as the Purchaser Representative, William Kerby in the Capacity as the Seller Representative, and Nexttrip Holdings, Inc., as the Company, Dated as of May 22, 2023

from 8-K 82 pages Business Combination Agreement by and Between Biolog-Id S.A. and Genesis Growth Tech Acquisition Corp. Dated as of August 26, 2022

from 425 82 pages Business Combination Agreement by and Between Biolog-Id S.A. and Genesis Growth Tech Acquisition Corp. Dated as of August 26, 2022

from 425 96 pages From: Genesis Growth Tech Acquisition Corp. a Cayman Islands Exempted Company Bahnhofstrasse 3 Hergiswil Nidwalden, Switzerland 6052 (The “Absorbed Company”) To: Biolog-Id 46-48 Avenue Du Général Leclerc 92100 Boulogne-Billancourt (The “Absorbing Company”) to the Attention of Mr Troy Hilsenroth, Chief Executive Officer Dated August 22, 2022 Strictly Private and Confidential Memorandum of Understanding Related to the Contemplated Merger of the Absorbing Company and the Absorbed Company 1. Option

from 8-K 96 pages From: Genesis Growth Tech Acquisition Corp. a Cayman Islands Exempted Company Bahnhofstrasse 3 Hergiswil Nidwalden, Switzerland 6052 (The “Absorbed Company”) To: Biolog-Id 46-48 Avenue Du Général Leclerc 92100 Boulogne-Billancourt (The “Absorbing Company”) to the Attention of Mr Troy Hilsenroth, Chief Executive Officer Dated August 22, 2022 Strictly Private and Confidential Memorandum of Understanding Related to the Contemplated Merger of the Absorbing Company and the Absorbed Company 1. Option